Lobbying client
EQRX INTERNATIONAL, INC.
Pharmaceutical manufacturer
Filings
18
Filed by
1
Reported in-house
—
Reported by firms
$320,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2019 to 2023
Filings
18 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination (No Activity) 4th Quarter 2023
|
ARENTFOX SCHIFF LLP | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2023
|
ARENTFOX SCHIFF LLP | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2023
|
ARENTFOX SCHIFF LLP | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2023
|
ARENTFOX SCHIFF LLP | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2022
|
ARENTFOX SCHIFF LLP | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2022
|
ARENTFOX SCHIFF LLP | — reported |
|
2nd Quarter - Report 2nd Quarter 2022
|
ARENTFOX SCHIFF LLP | $10,000 reported |
|
1st Quarter - Report 1st Quarter 2022
|
ARENTFOX SCHIFF LLP | $30,000 reported |
|
4th Quarter - Report 4th Quarter 2021
|
ARENTFOX SCHIFF LLP | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2021
|
ARENTFOX SCHIFF LLP | $30,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ARENTFOX SCHIFF LLP | 17 | $320,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 12 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.